UK Spy Chief Warns of Moment of Consequence From Russia and China Raising Geopolitical Risks Trumps Former AI Czar Halting AI Progress Would Be Equivalent to Stopping the US Economy WSJ Financial Services Roundup Market Talk Highlights on Experian and SoFi Technologies Global Implications Loom as World Leaders Monitor Potential TrumpXi Summit Enhanced Games Donald Trump JrBacked Steroid Olympics Set for Sunday Debut SpaceX Successfully Launches Starship on Second Attempt Advancing NextGen Rocket Development PDS Biotechnology Q1 2026 Earnings EPS Beat Highlights Progress Despite PreRevenue Status InspireMD Inc NSPR Q1 2026 Earnings Narrower Loss Than Expected But Shares Slide ONBPO Q1 2026 Earnings Preferred Stock Reports EPS of 061 Narrowly Misses Estimates JANX Q1 2026 Earnings Narrowed Loss Exceeds Expectations as Pipeline Progress Continues American Tower Q1 2026 Earnings Strong EPS Beat Amid Stable Property Operations Oxford Lane Capital Preferred Shares OXLCP Hold Steady Near Resistance After Modest Gain COMPASS Pathways CMPS Dips 2 as Stock Approaches Key Support Zone Asbury Automotive Group ABG Holds Steady Near Resistance on Modest Gains Park National Corporation Holds Steady as Support Levels Provide a Foundation Intellia Therapeutics NTLA Gains 186 as Gene Editing Stocks Find Support PRTA Q1 2026 Earnings EPS Surges 27169 Above Estimates Despite No Revenue Stock Edges Lower DNN Q1 2026 Earnings Large EPS Miss but Uranium Outlook Lifts Shares TYRA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment Okta Inc OKTA Q1 2026 Earnings EPS Beat Drives Modest Stock Gain Amid Revenue Ambiguity SUNC Q1 2026 Earnings Massive EPS Miss as SunocoCorp Reports Unexpected Loss Cisco Systems CSCO Q1 2026 Earnings EPS Slightly Beats Estimates Amid Strong Operational Performance AMD Commits 128 Billion to Taiwan Chip Ecosystem Challenging Nvidias Dominance JUNS Q4 2025 Earnings Narrower Loss Surprises Yet Stock Falls on PreRevenue Path MannKind Corporation MNKD Surges 44 Testing Key Resistance Amid Biotech Momentum